This report presents trends and outcomes of cardiac surgery following initial transcatheter aortic valve replacement (TAVR). The Society of Thoracic Surgeons (STS) Adult Cardiac Surgery Database was queried for all adult patients undergoing cardiac surgery after a previously placed TAVR between January 2012 and March 2023.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Valve disease
April 8, 2024
This webinar discusses the evidence supporting the Ross procedure and discusses the author's surgical technique.
March 1, 2024
As a part of the 2023 joint international conference of the African Academy for Pediatric and Congenital Heart Surgery and the African Association of Thoracic and Cardiovascular Surgeons, Professor Salvatore Lentini discussed the diagnosis and treatment of rheumatic heart disease in children.
November 15, 2023
CTSNet Congenital Editor Prof. Sameh Said spoke with Dr. Ahmad Ali Amirghofran about his pioneering method for valve construction from the right atrial appendage, demonstrated in “How to Make a Valve for the RVOT from the Right Atrial Appendage.”
October 4, 2023
A newly published review by Dr. David on aortic valve sparing operations
September 5, 2023
This video demonstrates a new modification to the periareolar approach, periareolar minimally invasive technique (PAMI).
August 4, 2023
Because of the potential risk of early structural valve deterioration, the FDA has sent notice about Abbott’s decision to stop selling and distributing Trifecta aortic surgical heart valves in the United States.
July 11, 2023
This article proposes a set of new techniques for mitral valve repair that employ a running suture rather than individual cords. They follow landmarks such as papillary muscle tips and free leaflet edge running and commissure so that there is little space left for guessing.
June 15, 2023
The authors performed a systematic review to determine whether direct oral anticoagulants (DOACs) are as safe and effective as vitamin K antagonists in the three months after bioprosthetic valve replacement.
June 1, 2023
A large RCT suggesting superiority of the transcatheter 'Alfieri' (Mitra-clip, edge to edge) repair over BMT.
.